Environmental obesogens reduce Thy1 expression and promote obesity

环境致肥胖因素降低Thy1表达并促进肥胖

基本信息

  • 批准号:
    8569119
  • 负责人:
  • 金额:
    $ 19.19万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-08-19 至 2015-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Obesity has risen dramatically over the last 30 years. In the U.S. alone, 60 million people are defined as clinically obese. Especially concerning is the nearly epidemic rate of childhood obesity. Obesity occurs through excessive adipogenesis (formation of adipocytes) or through increases in established adipocyte size. Environmental toxicants termed obesogens disrupt the endocrine system and can increase adipogenesis. Tributyltin (TBT), dichlorodiphenyl-dichloroethylene (DDE), bisphenol-A diglycidyl ether (BADGE), and tetrabromobisphenol-A (TBBPA), have been reported to increase obesity. The mechanism(s) by which xenobiotic obesogens function to disrupt the endocrine system and increase rates of obesity requires active investigation. Our work focuses on the surface glycoprotein, Thy1 (CD90). Thy1 is an glycophosphatidylinositol (GPI)-anchored membrane protein expressed on subsets of neurons, stem cells and other cell types. We discovered that fibroblasts are heterogeneous for expression of Thy1 and that only Thy1+ fibroblasts can differentiate into scar-forming myofibroblasts and only Thy1-/low fibroblasts can differentiate int adipocytes. In this R21 application, we hypothesize that there is a direct role for Thy1 in preventing adipogenesis. Our supporting data show that depletion of Thy1 increases adipogenesis while over- expression of Thy1 impairs adipogenesis. These data support the concept that Thy1 is more than a marker and that Thy1 can function to modify cell fate. We also discovered that Thy1 expression is reduced in both human and mouse multipotent stromal cells (MSCs) after exposure to TBBPA, BADGE and TBT. Importantly, one mechanism by which obesogens may function is to reprogram the epigenetic code of MSCs to alter physiology. The Thy1 locus contains multiple CpG islands that can be controlled epigenetically and may be key targets of obesogens. Developmental exposure to obesogens may reprogram Thy1 expression levels and modify physiology long after exposure. Therefore, we hypothesize that environmental obesogens alter Thy1 expression to increase adipogenesis and obesity. To investigate this hypothesis we have developed the following aims. Aim 1: Test the hypothesis that environmental obesogens diminish Thy1 expression and activity in multipotent stromal cells to increase adipogenesis. Aim 2: Test the hypothesis that developmental exposure to obesogens reduces Thy1 expression and increases adipogenesis and obesity in vivo. The results of these studies will show for the first time that Thy1 expression is reduced by environmental obesogens and this reduction is key to the mechanism whereby obesogens increase adipogenesis and obesity.
描述(由申请人提供):在过去的30年里,肥胖人数急剧上升。仅在美国,就有6000万人被诊断为临床肥胖。尤其令人担忧的是儿童肥胖几乎是流行病。肥胖的发生是由于过度的脂肪形成(脂肪细胞的形成)或由于既定脂肪细胞大小的增加。被称为肥胖源的环境毒物会破坏内分泌系统,增加脂肪生成。三丁基锡(TBT)、二氯二苯基二氯乙烯(DDE)、双酚- a二缩水甘油酯醚(BADGE)和四溴双酚- a (TBBPA)已被报道会增加肥胖。外源性致肥因子干扰内分泌系统和增加肥胖率的机制需要积极研究。我们的工作重点是表面糖蛋白Thy1 (CD90)。Thy1是一种糖磷脂酰肌醇(GPI)锚定的膜蛋白,在神经元、干细胞和其他细胞类型的亚群上表达。我们发现成纤维细胞表达Thy1是异质的,只有Thy1+的成纤维细胞才能分化成瘢痕形成的肌成纤维细胞,只有Thy1-/低的成纤维细胞才能分化成脂肪细胞。在这个R21应用中,我们假设Thy1在预防脂肪形成中有直接作用。我们的支持数据表明,Thy1的缺失增加了脂肪的形成,而Thy1的过表达则损害了脂肪的形成。这些数据支持这样一个概念,即Thy1不仅仅是一个标记,而且Thy1可以改变细胞命运。我们还发现,暴露于TBBPA、BADGE和TBT后,人和小鼠多能基质细胞(MSCs)中的Thy1表达均降低。重要的是,致肥因子可能发挥作用的一种机制是对MSCs的表观遗传密码进行重编程,从而改变生理机能。Thy1基因座包含多个CpG岛,这些岛可以通过表观遗传控制,可能是致肥因子的关键靶点。发育暴露于致肥源可能会在暴露后很长一段时间内重编程Thy1表达水平并改变生理。因此,我们假设环境致肥因子改变Thy1的表达,从而增加脂肪形成和肥胖。为了调查这一假设,我们制定了以下目标。目的1:验证环境致肥因子降低多能基质细胞中Thy1的表达和活性从而增加脂肪形成的假设。目的2:验证体内发育暴露于肥胖源降低Thy1表达并增加脂肪形成和肥胖的假设。这些研究结果将首次表明,环境致肥因子会降低Thy1的表达,而这种降低是致肥因子增加脂肪形成和肥胖的关键机制。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

RICHARD P. PHIPPS其他文献

RICHARD P. PHIPPS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('RICHARD P. PHIPPS', 18)}}的其他基金

Thy1 expression, adpogenesis, inflammation and orbital remodeling mechanisms in Thyroid Eye Disease
甲状腺眼病中 Thy1 表达、脂肪生成、炎症和眼眶重塑机制
  • 批准号:
    9213038
  • 财政年份:
    2017
  • 资助金额:
    $ 19.19万
  • 项目类别:
Dysregulation of common metabolic and transcriptional pathways in heart and lung fibrosis
心肺纤维化常见代谢和转录途径的失调
  • 批准号:
    9170621
  • 财政年份:
    2016
  • 资助金额:
    $ 19.19万
  • 项目类别:
Novel therapies for cigarette smoke induced lung injury
香烟烟雾引起的肺损伤的新疗法
  • 批准号:
    8758419
  • 财政年份:
    2014
  • 资助金额:
    $ 19.19万
  • 项目类别:
Novel therapies for cigarette smoke induced lung injury
香烟烟雾引起的肺损伤的新疗法
  • 批准号:
    9066785
  • 财政年份:
    2014
  • 资助金额:
    $ 19.19万
  • 项目类别:
Environmental obesogens reduce Thy1 expression and promote obesity
环境致肥胖因素降低Thy1表达并促进肥胖
  • 批准号:
    8723204
  • 财政年份:
    2013
  • 资助金额:
    $ 19.19万
  • 项目类别:
Aryl Hydrocarbon Receptor Ligands and Thyroid Eye Disease
芳基烃受体配体与甲状腺眼病
  • 批准号:
    9053494
  • 财政年份:
    2013
  • 资助金额:
    $ 19.19万
  • 项目类别:
Aryl Hydrocarbon Receptor Ligands and Thyroid Eye Disease
芳基烃受体配体与甲状腺眼病
  • 批准号:
    8843871
  • 财政年份:
    2013
  • 资助金额:
    $ 19.19万
  • 项目类别:
Aryl Hydrocarbon Receptor Ligands and Thyroid Eye Disease
芳基烃受体配体与甲状腺眼病
  • 批准号:
    8478945
  • 财政年份:
    2013
  • 资助金额:
    $ 19.19万
  • 项目类别:
Naturally Occurring Lipid Mediators Enhance Antibody Production
天然存在的脂质介质增强抗体产生
  • 批准号:
    8428228
  • 财政年份:
    2013
  • 资助金额:
    $ 19.19万
  • 项目类别:
Naturally Occurring Lipid Mediators Enhance Antibody Production
天然存在的脂质介质增强抗体产生
  • 批准号:
    8606727
  • 财政年份:
    2013
  • 资助金额:
    $ 19.19万
  • 项目类别:

相似国自然基金

相似海外基金

New development of cellular regeneration therapy in jaw bone using stem cells derived from adipocytes jaw bone
利用颌骨脂肪细胞来源的干细胞进行颌骨细胞再生治疗的新进展
  • 批准号:
    23K16058
  • 财政年份:
    2023
  • 资助金额:
    $ 19.19万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
A novel mechanism of insulin resistance mediated by uric acid metabolism in adipocytes
脂肪细胞尿酸代谢介导胰岛素抵抗的新机制
  • 批准号:
    23K10969
  • 财政年份:
    2023
  • 资助金额:
    $ 19.19万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Hypertrophic adipocytes as biophysical mediators of breast cancer progression
肥大脂肪细胞作为乳腺癌进展的生物物理介质
  • 批准号:
    10751284
  • 财政年份:
    2023
  • 资助金额:
    $ 19.19万
  • 项目类别:
Elucidation of mechanisms for conversion of adipocytes to cancer-associated fibroblasts in osteosarcoma microenvironment
阐明骨肉瘤微环境中脂肪细胞转化为癌症相关成纤维细胞的机制
  • 批准号:
    23K19518
  • 财政年份:
    2023
  • 资助金额:
    $ 19.19万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Study on UCP-1 independent metabolic regulation by brown adipocytes
棕色脂肪细胞对UCP-1独立代谢调节的研究
  • 批准号:
    23K18303
  • 财政年份:
    2023
  • 资助金额:
    $ 19.19万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Development of adipocytes for gene therapy that avoids cellular stress due to overexpression of therapeutic proteins
开发用于基因治疗的脂肪细胞,避免因治疗蛋白过度表达而造成的细胞应激
  • 批准号:
    23H03065
  • 财政年份:
    2023
  • 资助金额:
    $ 19.19万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Functional analysis of bitter taste receptors in adipocytes and hepatocytes
脂肪细胞和肝细胞中苦味受体的功能分析
  • 批准号:
    23K05107
  • 财政年份:
    2023
  • 资助金额:
    $ 19.19万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
NKA/CD36 signaling in adipocytes promotes oxidative stress and drives chronic inflammation in atherosclerosis
脂肪细胞中的 NKA/CD36 信号传导促进氧化应激并驱动动脉粥样硬化的慢性炎症
  • 批准号:
    10655793
  • 财政年份:
    2023
  • 资助金额:
    $ 19.19万
  • 项目类别:
The mechanisms of the signal transduction from brown adipocytes to afferent neurons and its significance.
棕色脂肪细胞向传入神经元的信号转导机制及其意义。
  • 批准号:
    23K05594
  • 财政年份:
    2023
  • 资助金额:
    $ 19.19万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
NKT cell activation depend on lipid accumulation in adipocytes
NKT 细胞的激活取决于脂肪细胞中的脂质积累
  • 批准号:
    22K08679
  • 财政年份:
    2022
  • 资助金额:
    $ 19.19万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了